MARCHF7

Chr 2

membrane associated ring-CH-type finger 7

Also known as: AXO, AXOT, MARCH-VII, MARCH7, RNF177

MARCH7 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH proteins add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments (Bartee et al., 2004 [PubMed 14722266]).[supplied by OMIM, Mar 2010]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
5
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.38
LOEUF
—
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.38LOEUF
pLI 0.662
Z-score 4.31
OE 0.20 (0.12–0.38)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.24Z-score
OE missense 0.97 (0.88–1.05)
348 obs / 360.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.20 (0.12–0.38)
0≤0.351.4
Missense OE?0.97 (0.88–1.05)
0≤0.61.4
Synonymous OE?1.01
0≤1.21.6
LoF obs/exp: 7 / 34.2Missense obs/exp: 348 / 360.6Syn Z: -0.06

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MARCHF7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →